World Advanced Therapies & Regenerative Medicine Congress

In May 2018, the 13th World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs.

From process development to clinical translation of cell, gene and immunotherapies this congress will bring you the most exciting case studies and new data. Experts in every area will help you tackle the process, manufacture, regulation, reimbursement, market access, process development of developing these new therapeutic formats all the way through manufacture and into the clinic.

Cell and Gene Therapy Catapult will be in attendence and will be taking part in the following sessions:

Wednesday 16th May 2018, 10:00
Delivering Advanced Therapies at scale: from manufacturing to the clinic
Keith Thompson, Chief Executive Officer

Wednesday 16th May 2018, 14:30                                                                       
Regulation, reimbursement & commercialisation of advanced therapies around the globe
Matthew Durdy, Chief Business Officer

Wednesday 16th May 2018, 17:05
Panel: A new landscape for investment and innovation in the UK
Matthew Durdy, Chief Business Officer

Wednesday 16th May 2018, 17:55
The transformation and clinical translation of regenerative medicine
Matthew Durdy, Chief Business Officer

Discover who we are